Moderna
MRNA
#1445
Rank
NZ$21.07 B
Marketcap
$54.51
Share price
-3.11%
Change (1 day)
-69.20%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - P/B ratio

P/B ratio as of March 2025 : 1.10

According to Moderna 's latest financial reports the company has a price-to-book ratio of 3.76108.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Moderna - P/B ratio (from 2018 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-311.29-52.69%
2023-12-312.74-24.15%
2022-12-313.61-50.43%
2021-12-317.28-54.9%
2020-12-3116.1188.09%
2019-12-315.6070.78%
2018-12-313.28
2017-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
1.50 35.89%๐Ÿ‡บ๐Ÿ‡ธ USA
4.86 340.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.0229-102.07%๐Ÿ‡บ๐Ÿ‡ธ USA
518 46,824.16%๐Ÿ‡บ๐Ÿ‡ธ USA
5.04 356.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
33.8 2,966.19%๐Ÿ‡บ๐Ÿ‡ธ USA
5.52 399.99%๐Ÿ‡บ๐Ÿ‡ธ USA